Local chemotherapy release

Local chemotherapy release refers to the use of implantable or injectable platforms, such as hydrogels, polymeric wafers, or nanoparticles, to provide controlled and sustained delivery of chemotherapeutic drugs directly at the tumor site, thereby limiting systemic exposure and toxicity while enhancing therapeutic concentration in the local tumor environment. These delivery systems are not themselves biological targets but are material-based vehicles designed to release drugs in response to local physiological conditions (e.g., pH, enzyme levels, redox state) or in a controlled, time-dependent manner. This method is especially valuable in cancers with high local recurrence rates or where systemic chemotherapy is associated with significant off-target toxicity. Examples include hydrogels releasing paclitaxel and pirfenidone for ECM-rich tumors, PLGA wafers loaded with carmustine for brain tumors, and various nanoparticle-based sustained release systems[1][2][4][5]. This entry is best categorized as a therapeutic method, not a canonical biological or molecular target.

Other names

Localized chemotherapy releaseLocalized drug deliveryLocal chemotherapy deliveryLocalized chemotherapy administrationSite-specific chemotherapy delivery

Local, sustained, and/or sequential release of chemotherapy at the tumor site to maximize intratumoral drug concentrations and minimize systemic toxicity[1][4][5]